These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28194913)

  • 1. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.
    Gisterå A; Hermansson A; Strodthoff D; Klement ML; Hedin U; Fredrikson GN; Nilsson J; Hansson GK; Ketelhuth DF
    J Intern Med; 2017 Apr; 281(4):383-397. PubMed ID: 28194913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model.
    Schaftenaar FH; Amersfoort J; Douna H; Kröner MJ; Foks AC; Bot I; Slütter BA; van Puijvelde GHM; Drijfhout JW; Kuiper J
    Sci Rep; 2019 Nov; 9(1):17391. PubMed ID: 31757993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
    Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
    Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice.
    Lu X; Xia M; Endresz V; Faludi I; Szabo A; Gonczol E; Mundkur L; Chen D; Kakkar V
    Atherosclerosis; 2012 Nov; 225(1):56-68. PubMed ID: 22959702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis.
    Hermansson A; Ketelhuth DF; Strodthoff D; Wurm M; Hansson EM; Nicoletti A; Paulsson-Berne G; Hansson GK
    J Exp Med; 2010 May; 207(5):1081-93. PubMed ID: 20439543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE
    Dunér P; Mattisson IY; Fogelstrand P; Glise L; Ruiz S; Farina C; Borén J; Nilsson J; Bengtsson E
    Sci Rep; 2021 Apr; 11(1):9022. PubMed ID: 33907226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory CD4
    Kimura T; Kobiyama K; Winkels H; Tse K; Miller J; Vassallo M; Wolf D; Ryden C; Orecchioni M; Dileepan T; Jenkins MK; James EA; Kwok WW; Hanna DB; Kaplan RC; Strickler HD; Durkin HG; Kassaye SG; Karim R; Tien PC; Landay AL; Gange SJ; Sidney J; Sette A; Ley K
    Circulation; 2018 Sep; 138(11):1130-1143. PubMed ID: 29588316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between circulating IgG antibodies to Apolipoprotein B
    Hu W; Zhang X; Han Y; Wang Y; Lei M; Megson IL; Wei J; Jin Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30242056
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice.
    Herbin O; Ait-Oufella H; Yu W; Fredrikson GN; Aubier B; Perez N; Barateau V; Nilsson J; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):605-12. PubMed ID: 22223728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination to modulate atherosclerosis.
    Kimura T; Tse K; Sette A; Ley K
    Autoimmunity; 2015 May; 48(3):152-60. PubMed ID: 25683179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.
    Engelbertsen D; Rattik S; Knutsson A; Björkbacka H; Bengtsson E; Nilsson J
    Cardiovasc Res; 2014 Jul; 103(2):304-12. PubMed ID: 24866382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Density Lipoprotein-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice.
    Gisterå A; Klement ML; Polyzos KA; Mailer RKW; Duhlin A; Karlsson MCI; Ketelhuth DFJ; Hansson GK
    Circulation; 2018 Nov; 138(22):2513-2526. PubMed ID: 29997115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ApoB100-mimetic vaccine prevents obesity and liver steatosis in ApoE-/- mice.
    Kong SK; Choe MK; Kim HJ; Kim YS; Binas B; Kim HJ
    Pharmacol Rep; 2017 Dec; 69(6):1140-1144. PubMed ID: 29128792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.
    Nilsson J; Björkbacka H; Fredrikson GN
    Curr Opin Lipidol; 2012 Oct; 23(5):422-8. PubMed ID: 22814703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in Atherosclerosis.
    Ley K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):429-38. PubMed ID: 26821946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
    Gonçalves I; Nitulescu M; Ares MP; Fredrikson GN; Jansson B; Li ZC; Nilsson J
    Atherosclerosis; 2009 Jul; 205(1):96-100. PubMed ID: 19150065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of apoB-100 Peptide-Specific CD8+ T Cells in Atherosclerosis.
    Dimayuga PC; Zhao X; Yano J; Lio WM; Zhou J; Mihailovic PM; Cercek B; Shah PK; Chyu KY
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28711866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic mice.
    Shattuck WM; Dyer MC; Desrosiers J; Fast LD; Terry FE; Martin WD; Moise L; De Groot AS; Mather TN
    Hum Vaccin Immunother; 2014; 10(10):3048-59. PubMed ID: 25517089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive Antigen Responses of LDL-Reactive CD4+ T Cells Induce Tr1 Cell-Mediated Immune Tolerance.
    Mailer RK; Konrath S; Zhan L; Thode H; Beerens M; Frye M; Ketelhuth DFJ; Renné T; Hansson GK
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1510-1523. PubMed ID: 37259863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.